Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales ...

At this time, I would like to welcome everyone to the 10X Genomics fourth quarter and full year 2024 earnings conference call. (Operator Instructions). I would now like to turn the conference over to ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Genomics, Inc. , a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2024 and provided outlook for ...

PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results ...

Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one ...

So, this combination makes it difficult to conclusively predict that 10x Genomics will beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue? Analysts often consider to ...

This collaboration will use 10x Genomics' Chromium GEM-X technology ... omics sets at low costs," said Gilad Almogy, Founder and CEO of Ultima Genomics. "Initiatives like the Billion Cells Project ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

The market expects 10x Genomics (TXG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...